EP300 and Miyoshi myopathy: In addition to the UTX inactivating mutations/deletions found in MM, inactivating mutations have also been detected in the components of COMPASS and its partner HATs, including KMT2C, CREBBP, and EP300 [16], further implicating dysregulated COMPASS activity in MM.